Brief: BRAIN Biotech 9M Adj. EBITDA at EUR -1.2 Million
29/08/2024 06:40
Aug 29 (Reuters) - BRAIN Biotech 9-month adjusted EBITDA EUR -1.2 million. * 9-month operating cash flow EUR -2.7 million * 9-month revenue EUR 40.4 million * 9-month EBITDA EUR -1.9 million
Recent news on BRAIN Biotech AG
See all newsBrief: BRAIN Biotech 9M EBITDA EUR -1.6 Million
CEOs Lukas Linnig And Michael Krohn To Leave Co
Brief: Brain Biotech Signs Exclusive Pharma Licensing Agreement With Akribion For Up To EUR 92.3 Million Milestone Fees Plus Royalties
Brief: BRAIN Biotech 9M Adj. EBITDA at EUR -1.2 Million
Europe Research Roundup: AB Foods, Bunzl, Barratt